BioCentury | Nov 25, 2020
Management Tracks

DBV CSO stepping down; plus moves at Idera, Ultimovacs, Omniome, Humacyte and Aelis Farma

...director of global business development at Amgen Inc. (NASDAQ:AMGN).Robert Wicke joined DNA sequencing platform company Omniome Inc....
...H. Lundbeck A/S (CSE:LUN) before retiring in 2018. Danielle Golovin DBV Technologies S.A. Idera Pharmaceuticals Inc. Ultimovacs A/S Genenta Science s.r.l. Omniome Inc. Humacyte...
BioCentury | Jan 10, 2020
Financial News

Jan. 9 Financial Quick Takes: Closes for two royalty funds; plus Apellis leads follow-on trio, Element, Omniome, Hinova, Emergex, Tscan, Calliditas

...$100 million. The company is developing a next-generation sequencing platform. Omniome raises $60M series C Omniome Inc....
...Calliditas Therapeutics AB (SSE:CALTX) filed to list ADSs on NASDAQ. BioCentury Staff Emergex Vaccines Holdings Ltd. TScan Therapeutics Inc. Omniome Inc. Hinova...
BioCentury | Aug 3, 2018
Finance

Appetite for Omniome

...An experienced team and a growing DNA sequencing market in China enabled San Diego’s Omniome Inc. to...
...we are assessing multiple options as part of our go-to-market plans in China.” Chris Lieu, Staff Writer Omniome Inc....
BioCentury | Aug 3, 2018
Financial News

Omniome raises $60M series B

...DNA sequencing company Omniome Inc. (San Diego, Calif.) raised $60 million on July 30 in a series...
...Omniome raised an undisclosed series A round in 2016. Omniome Inc., San Diego, Calif. Mary Romeo Decheng Capital Hillhouse Capital Omniome Inc....
BioCentury | Jul 30, 2018
Financial News

Omniome raises $60M series B

...DNA sequencing company Omniome Inc. (San Diego, Calif.) raised $60 million in a series B round led...
...of commercial sequencing platforms. Omniome raised an undisclosed series A round in 2016. Mary Romeo Decheng Capital Hillhouse Capital Omniome Inc....
Items per page:
1 - 5 of 5
BioCentury | Nov 25, 2020
Management Tracks

DBV CSO stepping down; plus moves at Idera, Ultimovacs, Omniome, Humacyte and Aelis Farma

...director of global business development at Amgen Inc. (NASDAQ:AMGN).Robert Wicke joined DNA sequencing platform company Omniome Inc....
...H. Lundbeck A/S (CSE:LUN) before retiring in 2018. Danielle Golovin DBV Technologies S.A. Idera Pharmaceuticals Inc. Ultimovacs A/S Genenta Science s.r.l. Omniome Inc. Humacyte...
BioCentury | Jan 10, 2020
Financial News

Jan. 9 Financial Quick Takes: Closes for two royalty funds; plus Apellis leads follow-on trio, Element, Omniome, Hinova, Emergex, Tscan, Calliditas

...$100 million. The company is developing a next-generation sequencing platform. Omniome raises $60M series C Omniome Inc....
...Calliditas Therapeutics AB (SSE:CALTX) filed to list ADSs on NASDAQ. BioCentury Staff Emergex Vaccines Holdings Ltd. TScan Therapeutics Inc. Omniome Inc. Hinova...
BioCentury | Aug 3, 2018
Finance

Appetite for Omniome

...An experienced team and a growing DNA sequencing market in China enabled San Diego’s Omniome Inc. to...
...we are assessing multiple options as part of our go-to-market plans in China.” Chris Lieu, Staff Writer Omniome Inc....
BioCentury | Aug 3, 2018
Financial News

Omniome raises $60M series B

...DNA sequencing company Omniome Inc. (San Diego, Calif.) raised $60 million on July 30 in a series...
...Omniome raised an undisclosed series A round in 2016. Omniome Inc., San Diego, Calif. Mary Romeo Decheng Capital Hillhouse Capital Omniome Inc....
BioCentury | Jul 30, 2018
Financial News

Omniome raises $60M series B

...DNA sequencing company Omniome Inc. (San Diego, Calif.) raised $60 million in a series B round led...
...of commercial sequencing platforms. Omniome raised an undisclosed series A round in 2016. Mary Romeo Decheng Capital Hillhouse Capital Omniome Inc....
Items per page:
1 - 5 of 5